Skip to main content
. 2022 Mar 9;61(6):869–879. doi: 10.1007/s40262-022-01114-5

Table 2.

Parameter estimates of the base model and the final model

Base model Final model
∆OFV −61.91
Fixed-effect parameters
 CL (L/h) 15.2 (5%) 14.7 (4.1%)
 V1 (L) 61.7 (7.1%) 61.2 (7.1%)
 Q (L/h) 44.3 (6.6%) 44.9 (6.7%)
 V2 (L) 72.1 (5.9%) 71.6 (6%)
eGFR on CL (linear) 0.008 (12%)
Random-effect parameters
 IIVCL 58.7% (14.2%) [7.6%] 47.2% (14.7%) [8.5%]
 IIVV1 62.1% (19.7%) [25%] 61.1% (19.7%) [25.2%]
 IIVV2 46.5% (23%) [36%] 46.8% (21.8%) [35%]
 IOVCL 16% (32.9%) [64.8%] 13.6% (38.7%) [65.2%]
Residual error
 AddStudy1 0.149 mg/L (27.7%) 0.151 mg/L (27.1%)
 PropStudy1 17.5% (9.5%) 17.5% (9.5%)
 PropStudy2 13.8% (3.6%) 13.7% (3.6%)
 PropStudy3 24.2% (5.2%) 24.5% (5.1%)

The relative standard error is shown within the parenthesis and the shrinkage is shown within the square bracket

Add additive residual error, CL clearance, eGFR estimated glomerular filtration rate using the MDRD equation, IIV inter-individual variability, IOV inter-occasion variability, OFV objective function value, Prop proportional residual error, Q inter-compartmental clearance, V1 central volume of distribution, V2 peripheral volume of distribution